Detailed View
SYRE - Spyre Therapeutics, Inc.
Latest filing: 2025-12-31 | Reporting: gaap
Market Cap
5,979,499,008
Adj EBIT (TTM)
-209,562,000
Enterprise Value
5,974,974,008
Last Price
69.42
Earnings Yield
-3.51%
Return on Capital
-29.14%
Capital
719,096,000
1Y Price Chart
Last Price: $69.42
1Y Change: 373.53%
As of 2026-05-01 | 1Y Change: 373.53%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 0 | -57,172,000 |
| 2025-09-30 | 10-Q | 2025 | 0 | -56,888,000 |
| 2025-06-30 | 10-Q | 2025 | 0 | -41,935,000 |
| 2025-03-31 | 10-Q | 2025 | 0 | -53,567,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 0 | -61,253,000 |
| 2024-09-30 | 10-Q | 2024 | 0 | -55,392,000 |
| 2024-06-30 | 10-Q | 2024 | 0 | -44,147,000 |
| 2024-03-31 | 10-Q | 2024 | 0 | -47,774,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.